Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]
NYS Entity Status
NYS Filing Date
FEBRUARY 06, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2013 - COGNITIVE THERAPY OF NEW YORK, LCSW, P.C.
Around the Web
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
- FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
By Ben Fidler - Tuesday Aug 29, 2017
The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]
- New York Today: New York Today: New Subway Clocks
By JONATHAN WOLFE - Monday Aug 7, 2017
Monday: Rolling out new subway clocks, the Corkscrew Theater Festival, and National Lighthouse Day.
- Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
By David Holley - Tuesday Jun 20, 2017
Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]
- Restaurant Review: Lost in New York at Public Kitchen
By PETE WELLS - Tuesday Oct 10, 2017
At Jean-Georges Vongerichten’s new restaurant on the Lower East Side, the menu is supposed to be inspired by the whole city.